Eli Lilly and Company
Public
LLY
SectorHealthcare
CountryUnited States
Market cap805.82B
Eli Lilly and Company is a global pharmaceutical leader at the forefront of the healthcare industry's most significant growth cycle in decades. Headquartered in Indianapolis, Indiana, the company has transitioned from a traditional drugmaker into a high-growth biotech powerhouse, primarily driven by its dominance in the incretin (weight loss and diabetes) market.
